ESC 365 - Outcomes of heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation

EHRA Premium Access

Outcomes of heart failure with preserved ejection fraction after radiofrequency catheter ablation for atrial fibrillation

Session: Pathophysiology of atrial fibrillation and beyond II

Topic: Mechanisms for Stroke

Speaker: Assistant Professor T. Zolotarova (Kharkiv, UA)

Event: EHRA 2021

Congress Session

About the speaker

Assistant Professor Tetiana Zolotarova

V.N. Karazin National University, Kharkiv (Ukraine)

0 follower

6 more presentations in this session

Conduction and voltage characteristics associated with new-onset postoperative atrial fibrillation

Speaker: Mr M. Van Schie (Rotterdam, NL)

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation?

Speaker: Assistant Professor V. Ionin (Saint-Petersburg, RU)

Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.

Speaker: Doctor F. Biccire (Rome, IT)

Application of recurrence plot analysis to characterise whole chamber propagation of atrial fibrillation

Speaker: Doctor M. Pope (Oxford, GB)

The onset of paroxysmal non-valvular atrial fibrillation in men with hypertension is associated with an increase in blood levels of transforming growth factor beta 1

Speaker: Professor S. Koval (Kharkiv, UA)

Access the full session

Pathophysiology of atrial fibrillation and beyond II

Speakers: Assistant Professor T. Zolotarova, Mr M. Van Schie, Assistant Professor V. Ionin, Doctor F. Biccire, Doctor M. Pope...

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

Related content

EHRA Premium Access

Hot topics in atrial fibrillation.

5 April 2022

Open Access

PROFID: risk score to predict the individual sudden cardiac death (SCD) risk and identify those post-MI patients that will optimally benefit from an implantable cardioverter defibrillator (ICD).

3 April 2022

ESC Premium Access

Digital health: patient perspectives

22 October 2021

This platform is supported by